Rhenium-186 hydroxyethylidene diphosphonate (Re-186 HEDP) dose escalation study in patients with metastasized prostate cancer: Target organ dosimetry, marrow toxicity and optimized data collection Meeting Abstract

  

Authors:	Graham, M. C.; Liu, G. B.; Daghighian, F.; Yeh, S. D. J.; Scher, H.; Curley, T.; Larson, S. M.
Abstract Title:	Rhenium-186 hydroxyethylidene diphosphonate (Re-186 HEDP) dose escalation study in patients with metastasized prostate cancer: Target organ dosimetry, marrow toxicity and optimized data collection
Meeting Title:	41st Annual Meeting of the Society of Nuclear Medicine
Journal Title:	Journal of Nuclear Medicine
Volume:	35
Issue:	5 Suppl.
Meeting Dates:	1994 Jun 5-8
Meeting Location:	Orlando, FL
ISSN:	0161-5505
Publisher:	Society of Nuclear Medicine
Date Published:	1994-05-01
Start Page:	36P
End Page:	37P
Language:	English
ACCESSION:	WOS:A1994NK90900137
PROVIDER:	wos
PUBMED:	8164062
Notes:	Meeting Abstract: 137 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/142457